LeonaBio (LONA) Other Non-Current Assets (2020 - 2026)
LeonaBio (LONA) reported Other Non-Current Assets of $631000.0 for Q1 2026, little changed year-over-year from $631000.0 in Q1 2025, and little changed quarter-over-quarter from $631000.0 in Q4 2025.
LeonaBio (LONA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
LeonaBio (LONA) has 7 years of Other Non-Current Assets data on file, last reported at $631000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $631000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $631000.0 (changed 0.0% YoY), and the FY2025 annual result was $631000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was little changed at $631000.0 in Q1 2026 per LONA's latest filing, from $631000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $631000.0 in Q3 2023 and troughed at $55000.0 in Q3 2022.
- A 5-year average of $368000.0 and a median of $420000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets soared 1047.27% in 2023, then sank 91.28% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $420000.0 in 2022, then jumped by 50.24% to $631000.0 in 2023, then changed by 0.0% to $631000.0 in 2024, then changed by 0.0% to $631000.0 in 2025, then changed by 0.0% to $631000.0 in 2026.
- Business Quant data shows LONA's Other Non-Current Assets at $631000.0 in Q1 2026, $631000.0 in Q4 2025, and $55000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | 631,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 631,000.00 |
| Dec 31, 2025 | 631,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 631,000.00 |
| Mar 31, 2025 | 631,000.00 |
| Dec 31, 2024 | 631,000.00 |
| Sep 30, 2024 | 55,000.00 |
| Jun 30, 2024 | 55,000.00 |
| Mar 31, 2024 | 631,000.00 |
| Dec 31, 2023 | 631,000.00 |
| Sep 30, 2023 | 631,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Mar 31, 2023 | 72,000.00 |
| Dec 31, 2022 | 420,000.00 |
| Sep 30, 2022 | 55,000.00 |
| Jun 30, 2022 | 210,000.00 |
| Mar 31, 2022 | 225,000.00 |
| Dec 31, 2021 | 56,000.00 |
| Sep 30, 2021 | 125,000.00 |
| Jun 30, 2021 | 225,000.00 |